Search Results 711-720 of 21287 for anti-TNF drugs

  1. Lacosamide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

    A phase 1 study finds low incidence of severe side effects and high response rate for ide-cel, an anti-BCMA CAR-T cell therapy for relapsed or refractory ...

  3. Acetaminophen And Codeine (Oral Route) Description and Brand Names - Mayo Clinic

    Codeine belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain. When codeine ...

  4. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as capecitabine ... anti-EGFR antibody (if tumor is RAS wild-type) ... TNF] agents) =< 14 days prior to randomization ...

  5. Etonogestrel (Intradermal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Proton Beam Therapy Program - About Mayo Clinic's program

    The Proton Beam Therapy Program is directed by the Mayo Clinic Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive ...

  7. Tuberous sclerosis - Diagnosis and treatment - Mayo Clinic

    Medicine. Anti-seizure medicines may be prescribed to control seizures. Other medicines may help manage heart rhythm problems, behavior problems or other ...

  8. Ethinyl Estradiol And Norelgestromin (Transdermal Route) Before Using - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  9. Targeting VEGF-Independent Proangiogenic Pathways in Anti-VEGF Refractory Renal Cell Cancer - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    Mukhopadhyay's lab is developing novel treatment strategies to target these pathways for refractory and highly aggressive tumor types and for sarcomatoid renal ...

  10. Tropicamide (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Mydral; Mydriacyl; Ocu-Tropic; Tropicacyl. Descriptions.